COVID-19 Treatment Studied by Vanderbilt University Medical Center Gains FDA Approval
October 27, 2020
October 27, 2020
NASHVILLE, Tennessee, Oct. 27 (TNSJou) -- Vanderbilt University Medical Center issued the following news:
Researchers at Vanderbilt University Medical Center played a key role in the development of remdesivir, the first drug approved by the U.S. Food and Drug Administration for the treatment of COVID-19.
The FDA announced (https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19) last week that it had approved remdesivir for use in adult . . .
Researchers at Vanderbilt University Medical Center played a key role in the development of remdesivir, the first drug approved by the U.S. Food and Drug Administration for the treatment of COVID-19.
The FDA announced (https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19) last week that it had approved remdesivir for use in adult . . .